Home Resources Podcasts STEM CELL THERAPIES ON THE RISE STEM CELL THERAPIES ON THE RISE February 5, 2009 0 – Linda Powers, Cofounder and Managing Director of Toucan Capital, is interviewed by GEN’s Editor in Chief, John Sterling /wp-content/uploads/2018/09/gc249_2_5_2009.mp3 PodcastsResourcesTranslational MedicineCell therapyClinical trialDrug research and developmentEmbryonic stem cellsGenetic engineeringGenetic Engineering and BiotechnologyMedicineMedicine, Diagnosis, and TherapeuticsPharmacologyPluripotent stem cellsRegenerative engineeringResearch and developmentResearch resourcesStem cell engineeringStem cellsTherapeuticsTranslational medicine Also of InterestRelated MediaNews | Translational Medicine | How Blood That Leaks into the Brain Makes Immune Cells ToxicDrug Discovery | Insights | Charms to Soothe the Savage MicrobiomeArtificial Intelligence | Drug Discovery | News | ChatGPT-Like Model “Speaks Protein” to Speed Drug DiscoveryDrug Discovery | Insights | Breath Can Deepen Our Understanding of the MicrobiomeGenome Editing | Insights | Base Editors and Prime Editors Begin to Realize Their Clinical PromiseBioprocessing | Insights | Prospects for the Oral Delivery of BiopharmaceuticalsGEN Edge | News | Resources | BIO CEO Rachel King Outlines Industry’s Challenges on “Close to the Edge”GEN Edge | OMICs | Resources | Carl Icahn States His Case for Change at Illumina on “Close to the Edge”News | OMICs | Resources | Celebrating DNA: Matthew Cobb’s Reflections on the Double HelixDrug Discovery | Resources | Sponsored | Emerging Markets Collaborate to Succeed in Post-Pandemic WorldInsights | Resources | Book Review: The ExceptionsGEN Edge | Genome Editing | News | Resources | Search and Replace: Andrew Anzalone Details How Genome Editing Went Prime Time on “Close to the Edge” LEAVE A REPLY Cancel replyLog in to leave a comment